Advertisement
All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter's exclusive daily reports. As a subscriber, you'll also gain access to our Recommended List of stocks, which outperformed the S&P 500 by 15% in 2008.
Advertisement
All trial subscribers will also receive our recently published special report "Nine High-Yield Stocks for '09" for free. This 38-page report gives an in-depth examination of nine high-yielding stocks that could help get investors through this difficult market. The report digs into each stock's dividend history, business activities, strengths, weaknesses, latest earnings report, and much more.
Start your 14-day free trial today: https://www.bullmarket.com/subscribe/pr/?refer=BMR457P
In its daily report, BullMarket.com wrote: "The final area of Obama's suggested spending, on bringing 21st century technology to the keeping of healthcare records, is one of the most exciting in our view given that many hospitals and doctors seem to have overlooked 20th century technology let alone newer tools. It is estimated that 90% of U.S. doctors and at least two-thirds of the country's hospitals still rely on paper patient records."
BullMarket.com looked at the following topics, among others:
-- Why is athenahealth's business model very attractive?
-- What are some of the catalysts and headwinds Cerner faces?
-- Can Quality System's stock continue its recent strong run?
-- Does Allscripts' recent merger with Misys look like a good one?
-- Which healthcare IT stocks are BullMarket.com's favorites for 2009?
About BullMarket.com:
Launched in 1997, BullMarket.com has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The BullMarket.com Recommended List includes about 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. BullMarket.com is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices.
NOTE: This release was published by Indie Research Advisors, LLC (CRD #131926), a registered investment advisor with the NASD and State of NJ. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contacts Indie Research Advisors, LLC Marcie Martin, +1-888-278-5515
SOURCE Indie Research Advisors, LLC
